Peptide Targeted Lipid Nanoparticles for Anticancer Drug Delivery

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Advances in Materials

• Publication date

  2012-07-24

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1002/adma.201200832PMID 22674563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Oncogene].

  2019cited by this paper
• Polymersomes functionalized via “click” chemistry with the fibronectin mimetic peptides PR_b and GRGDSP for targeted delivery to cells with different levels of α5β1 expression

  2012cited by this paper
• Anthracyclines in the Treatment of Cancer

  2012cited by this paper
• Targeting properties of peptide-modified radiolabeled liposomal nanoparticles.

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Enhanced integrin mediated signaling and cell cycle progression on fibronectin mimetic peptide amphiphile monolayers.

  2012cited by this paper
• LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor.

  2012cited by this paper
• Recent advances in pathway-targeted cancer drug therapies emerging from cancer genome analysis.

  2012cited by this paper
• PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.

  2012cited by this paper
• Targeted Therapies in Metastatic Renal Cell Carcinoma: Overview of the Past Year

  2012cited by this paper
• Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

  2011cited by this paper
• Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice.

  2011cited by this paper
• Delivery of nanoparticle‐complexed drugs across the vascular endothelial barrier via caveolae

  2011cited by this paper
• Targeted drug delivery to tumors: myths, reality and possibility.

  2011cited by this paper
• Increasing the antitumor efficacy of doxorubicin-loaded liposomes with peptides anchored via a chelator lipid

  2011cited by this paper
• Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies

  2011cited by this paper
• RGD-targeted paramagnetic liposomes for early detection of tumor: in vitro and in vivo studies.

  2011cited by this paper
• Novel tetrapeptide, RGDF, mediated tumor specific liposomal doxorubicin (DOX) preparations.

  2011cited by this paper
• Reduction-triggered delivery using nucleoside-lipid based carriers possessing a cleavable PEG coating.

  2011cited by this paper
• Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration.

  2011cited by this paper
• Peptide‐labeled supramolecular aggregates as selective doxorubicin carriers for delivery to tumor cells

  2011cited by this paper
• A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor.

  2011cited by this paper
• Pharmacokinetic Dose-Scheduling Study of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors

  2011cited by this paper
• Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors.

  2011cited by this paper
• Pep-1 Peptide-modified liposomal carriers for intracellular delivery of gold nanoparticles.

  2011cited by this paper
• pH-Sensitive PEGylated liposomes functionalized with a fibronectin-mimetic peptide show enhanced intracellular delivery to colon cancer cell.

  2011cited by this paper
• Targeting kidney mesangium by nanoparticles of defined size

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin.

  2011cited by this paper
• Effective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculature.

  2011cited by this paper
• Target‐Selective Drug Delivery through Liposomes Labeled with Oligobranched Neurotensin Peptides

  2011cited by this paper
• More effective nanomedicines through particle design.

  2011cited by this paper
• LyP-1-conjugated doxorubicin-loaded liposomes suppress lymphatic metastasis by inhibiting lymph node metastases and destroying tumor lymphatics

  2011cited by this paper
• Nanomedicine in cancer therapy: Innovative trends and prospects

  2011cited by this paper
• Endocytosis of nanomedicines.

  2010cited by this paper
• Strategies in the design of nanoparticles for therapeutic applications

  2010cited by this paper
• Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies.

  2010cited by this paper
• Cancer chemotherapy with lipid-based nanocarriers.

  2010cited by this paper
• A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models.

  2010cited by this paper
• Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein.

  2010cited by this paper
• Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency.

  2010cited by this paper
• Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein.

  2010cited by this paper
• Targeting of drugs and nanoparticles to tumors

  2010cited by this paper
• Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes

  2010cited by this paper
• Lipid‐based nanotherapeutics for siRNA delivery

  2010cited by this paper
• Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.

  2010cited by this paper
• A novel DDS strategy, "dual-targeting", and its application for antineovascular therapy.

  2010cited by this paper
• Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer

  2010cited by this paper
• Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome.

  2010cited by this paper
• Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake.

  2010cited by this paper
• Liposomes modified with YIGSR peptide for tumor targeting

  2010cited by this paper
• Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78

  2010cited by this paper
• Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma.

  2010cited by this paper
• Binding of the fibronectin-mimetic peptide, PR_b, to alpha5beta1 on pig islet cells increases fibronectin production and facilitates internalization of PR_b functionalized liposomes.

  2010cited by this paper
• Peptide modified nanocarriers for selective targeting of bombesin receptors.

  2010cited by this paper
• Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.

  2010cited by this paper
• Preparation of RGD-modified Long Circulating Liposome Loading Matrine, and its in vitro Anti-cancer Effects

  2010cited by this paper
• Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.

  2010cited by this paper
• Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicin

  2010cited by this paper
• Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging.

  2010cited by this paper
• Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.

  2010cited by this paper
• PHSCNK-Modified and doxorubicin-loaded liposomes as a dual targeting system to integrin-overexpressing tumor neovasculature and tumor cells

  2010cited by this paper
• Internalization of p53(14-29) peptide amphiphiles and subsequent endosomal disruption results in SJSA-1 cell death.

  2010cited by this paper
• Fibroblast growth factor signalling: from development to cancer

  2010cited by this paper
• Integrins in cancer: biological implications and therapeutic opportunities

  2010cited by this paper
• Novel peptide ligand directs liposomes toward EGF‐R high‐expressing cancer cells in vitro and in vivo

  2009cited by this paper
• Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements

  2009cited by this paper
• Cooperative nanomaterial system to sensitize, target, and treat tumors

  2009cited by this paper
• A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung Cancer

  2009cited by this paper
• Antiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors*

  2009cited by this paper
• Nanocarriers’ entry into the cell: relevance to drug delivery

  2009cited by this paper
• Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.

  2009cited by this paper
• A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells.

  2009cited by this paper
• Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1.

  2009cited by this paper
• RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer

  2009cited by this paper
• PR_b-targeted delivery of tumor necrosis factor-α by polymersomes for the treatment of prostate cancer

  2009cited by this paper
• Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.

  2009cited by this paper
• Somatostatin, cortistatin and their receptors in tumours.

  2008cited by this paper
• Nanoparticle-mediated cellular response is size-dependent.

  2008cited by this paper
• Stress Chaperone GRP78/BiP Confers Chemoresistance to Tumor-Associated Endothelial Cells

  2008cited by this paper
• PR_b-targeted PEGylated liposomes for prostate cancer therapy.

  2008cited by this paper
• Antibody-targeted liposomes in cancer therapy and imaging

  2008cited by this paper
• Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals.

  2008cited by this paper
• Molecular imaging of tumor angiogenesis using αvβ3-integrin targeted multimodal quantum dots

  2008cited by this paper
• Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.

  2008cited by this paper
• Noninvasive assessment of cancer response to therapy

  2008cited by this paper
• Epidermal growth factor receptor mutations in lung cancer

  2007cited by this paper
• Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.

  2007cited by this paper
• Targeting the neural cell adhesion molecule in cancer.

  2007cited by this paper
• Chem. Pharm. Bull.(オピニオン)

  2007cited by this paper
• Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid

  2007cited by this paper
• ErbB receptors: from oncogenes to targeted cancer therapies.

  2007cited by this paper
• Endocytic mechanisms for targeted drug delivery.

  2007cited by this paper
• Sheddable Coatings for Long-Circulating Nanoparticles

  2007cited by this paper
• Solid lipid nanoparticles as a drug delivery system for peptides and proteins.

  2007cited by this paper
• Nanocarriers as an emerging platform for cancer therapy.

  2007cited by this paper
• Renal clearance of quantum dots

  2007cited by this paper
• GRP78/BiP Is Required for Cell Proliferation and Protecting the Inner Cell Mass from Apoptosis during Early Mouse Embryonic Development

  2006cited by this paper
• US Department of Health and Human Services: a need for global health leadership in preparedness and health diplomacy.

  2006cited by this paper
• Self-assembly and applications of biomimetic and bioactive peptide-amphiphiles.

  2006cited by this paper

• pH-responsive polymeric-peptide complex enhances tumor immunogenic cell death by membrane disruption.

  2026cites this paper
• The Burst Enhancement of MRI Using Magnetic Resonance Tuning Based Contrast Agents.

  2025cites this paper
• Antiproliferative effect of ketogenic diet on hormone independent mammary gland carcinoma via harnessing glucose metabolism: In-vitro and In-vivo investigations

  2025cites this paper
• Microfluidic Fabrication of Oleosin-Coated Liposomes as Anticancer Drug Carriers with Enhanced Sustained Drug Release

  2024cites this paper
• Strategies for Organ-Targeted mRNA Delivery by Lipid Nanoparticles.

  2024cites this paper
• Intravitreal therapeutic nanoparticles for age-related macular degeneration: Design principles, progress and opportunities.

  2024cites this paper
• Amyloids, amorphous aggregates and assemblies of peptides - Assessing aggregation.

  2024cites this paper
• Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications

  2024cites this paper
• Navigating cancer therapy: Harnessing the power of peptide-drug conjugates as precision delivery vehicles.

  2024cites this paper
• Comparative analysis of lipid-peptide nanoparticles prepared via microfluidics, reverse phase evaporation, and ouzo techniques for efficient plasmid DNA delivery.

  2024cites this paper
• Action Programmed Nanoantibiotics with pH‐Induced Collapse and Negative‐Charged‐Surface‐Induced Deformation against Antibiotic‐Resistant Bacterial Peritonitis

  2024cites this paper
• Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging

  2024cites this paper
• Smart and bioinspired systems for overcoming biological barriers and enhancing disease theranostics

  2023cites this paper
• A review of FDA approved drugs and their formulations for the treatment of breast cancer

  2023cites this paper
• Synthesis of nanoparticles via microfluidic devices and integrated applications

  2023cites this paper
• Surface Functionalization of Gold Nanoparticles for Targeting the Tumor Microenvironment to Improve Antitumor Efficiency.

  2023cites this paper
• Perspectives and trends in advanced optical and electrochemical biosensors based on engineered peptides

  2023cites this paper
• RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy

  2023cites this paper
• Surface modification of lipid nanoparticles for gene therapy

  2023cites this paper
• Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics

  2023cites this paper
• Self‐Assembling Peptide‐Based Functional Biomaterials

  2022cites this paper
• Polymer/magnetite carriers functionalized by HER2-DARPin: Avoiding lysosomes during internalization and controlled toxicity of doxorubicin by focused ultrasound induced release.

  2022cites this paper
• Synthetic polymer material modified by d-peptide and its targeted application in the treatment of non-small cell lung cancer.

  2022cites this paper
• In Vitro and In Vivo Evaluation of a Cyclic LyP-1-Modified Nanosystem for Targeted Endostatin Delivery in a KYSE-30 Cell Xenograft Athymic Nude Mice Model

  2022cites this paper
• Novel Microfluidic Swirl Mixers for Scalable Formulation of Curcumin Loaded Liposomes for Cancer Therapy.

  2022cites this paper
• Reprogramming Adeno-Associated Virus Tropism Via Displayed Peptides Tiling Receptor-Ligands

  2022cites this paper
• Dual “Unlocking” Strategy to Overcome Inefficient Nanomedicine Delivery and Tumor Hypoxia for Enhanced Photodynamic‐Immunotherapy

  2022cites this paper
• The engineering challenges and opportunities when designing potent ionizable materials for the delivery of ribonucleic acids

  2022cites this paper
• Charge/Size Dual-Rebound Gene Delivery System

  2021cites this paper
• Current Understandings and Clinical Translation of Nanomedicines for Breast Cancer Therapy.

  2021cites this paper
• Enhanced delivery of artesunate by stimuli-responsive polymeric micelles for lung tumor therapy

  2021cites this paper
• Recent advances in peptide-based nanomaterials for targeting hypoxia

  2021cites this paper
• A multiple environment-sensitive prodrug nanomicelle strategy based on chitosan graftomer for enhanced tumor therapy of gambogic acid.

  2021cites this paper
• Protection against proteolysis of a targeting peptide on gold nanostructures.

  2021cites this paper
• Bioorthogonal Pretargeting Strategy for Anchoring Activatable Photosensitizers on Plasma Membranes for Effective Photodynamic Therapy.

  2021cites this paper
• Natural and Synthetic Biopolymers in Drug Delivery and Tissue Engineering

  2021cites this paper
• Magnetic nanoparticles applied in targeted therapy and magnetic resonance imaging: crucial preparation parameters, indispensable pre-treatments, updated research advancements and future perspectives.

  2020cites this paper
• Nanotechnology for COVID-19: Therapeutics and Vaccine Research

  2020cites this paper
• Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy

  2020cites this paper
• Physics in nanomedicine: Phenomena governing the in vivo performance of nanoparticles

  2020cites this paper
• Lymph node targeting for improved potency of cancer vaccine

  2020cites this paper
• Tumor microenvironment-induced structure changing drug/gene delivery system for overcoming delivery-associated challenges.

  2020cites this paper
• The Possible Uses and Challenges of Nanomaterials in Mast Cell Research

  2020cites this paper
• Multivalent Aptamer-modified DNA Origami as Drug Delivery System for Targeted Cancer Therapy

  2019cites this paper
• PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release.

  2019cites this paper
• Surface Modification of Nanoparticles for Targeted Drug Delivery

  2019influential citation
• Delivering Combination Chemotherapies and Targeting Oncogenic Pathways via Polymeric Drug Delivery Systems

  2019cites this paper
• Logical design and application of prodrug platforms

  2019cites this paper
• Surface-Functionalized Lipid Nanoparticles for Site-Specific Drug Delivery

  2019cites this paper
• Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems.

  2019cites this paper
• Enhancement mitochondrial apoptosis in breast cancer cells by paclitaxel-triphenylphosphonium conjugate in DNA aptamer modified nanoparticles

  2019cites this paper
• Kidney-targeted rhein-loaded liponanoparticles for diabetic nephropathy therapy via size control and enhancement of renal cellular uptake

  2019cites this paper
• Green synthesis of zinc nanoparticles through plant extracts: establishing a novel era in cancer theranostics

  2019cites this paper
• Recent Design and Structure-Activity Relationship Studies on Modifications of DHFR Inhibitors as Anticancer Agents.

  2019cites this paper
• Magnetosomes Extracted from Magnetospirillum gryphiswaldense as Theranostic Agents in an Experimental Model of Glioblastoma

  2018cites this paper
• The molecularly imprinted polymer essentials: curation of anticancer, ophthalmic, and projected gene therapy drug delivery systems.

  2018cites this paper
• A dual redox-responsive supramolecular amphiphile fabricated by selenium-containing pillar[6]arene-based molecular recognition.

  2018cites this paper
• Targeted chemotherapy for subcutaneous and orthotopic non-small cell lung tumors with cyclic RGD-functionalized and disulfide-crosslinked polymersomal doxorubicin

  2018cites this paper
• Perceived risks and benefits of nanomedicine: a case study of an anti-tuberculosis drug

  2018cites this paper
• Background-Free Imaging of a Viral Capsid Proteins Coated Anisotropic Nanoparticle on a Living Cell Membrane with Dark-Field Optical Microscopy.

  2018cites this paper
• Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers

  2018cites this paper
• Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery

  2018cites this paper
• Peptide‐Based Multifunctional Nanomaterials for Tumor Imaging and Therapy

  2018cites this paper
• Smart Drug-Delivery Systems for Cancer Nanotherapy.

  2018cites this paper
• Camptothecin prodrug nanomicelle based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake

  2018cites this paper
• Optimized peptide based inhibitors targeting the dihydrofolate reductase pathway in cancer

  2018cites this paper
• Far-red light-mediated programmable anti-cancer gene delivery in cooperation with photodynamic therapy.

  2018cites this paper
• Biodegradable Cyclomatrix Polyphosphazene Nanoparticles: A Novel pH-Responsive Drug Self-Framed Delivery System.

  2018cites this paper
• Dual redox/pH-responsive hybrid polymer-lipid composites: Synthesis, preparation, characterization and application in drug delivery with enhanced therapeutic efficacy

  2018cites this paper
• Amplifying Nanoparticle Targeting Performance to Tumor via Diels–Alder Cycloaddition

  2018cites this paper
• Aptamer micelles targeting fractalkine-expressing cancer cells in vitro and in vivo.

  2018cites this paper
• A Transformable Chimeric Peptide for Cell Encapsulation to Overcome Multidrug Resistance.

  2018cites this paper
• Nanopurpurin-based photodynamic therapy destructs extracellular matrix against intractable tumor metastasis.

  2018cites this paper
• A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.

  2018cites this paper
• Peptide chemistry encounters nanomedicine: recent applications and upcoming scenarios in cancer.

  2018cites this paper
• Application of Light Scattering Techniques to Nanoparticle Characterization and Development

  2018influential citation
• Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted ‘magic bullets’ to self-navigated ‘magic missiles’

  2017cites this paper
• A Smart Metal-Organic Framework Nanomaterial for Lung Targeting.

  2017cites this paper
• Peptide-Based Stealth Nanoparticles for Targeted and pH-Triggered Delivery.

  2017cites this paper
• Polymeric micelles self-assembled from amphiphilic polymers with twin disulfides used as siRNA carriers to enhance the transfection.

  2017cites this paper
• Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles

  2017cites this paper
• Liposome as nanocarrier: Site targeted delivery in lung cancer

  2017cites this paper
• Ultrasmall Conjugated Polymer Nanoparticles with High Specificity for Targeted Cancer Cell Imaging

  2017cites this paper
• Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization

  2017cites this paper
• Construction of biomimetic long-circulation delivery platform encapsulated by zwitterionic polymers for enhanced penetration of blood–brain barrier

  2017cites this paper
• 4.16 Surface Engineering Using Amphiphilic Peptides

  2017cites this paper
• Nanomedicine for prostate cancer using nanoemulsion: A review

  2017cites this paper
• The design of peptide‐amphiphiles as functional ligands for liposomal anticancer drug and gene delivery

  2017cites this paper
• Cancer Nanomedicine: Lessons for Immuno-Oncology.

  2017cites this paper
• Dual‐ligand &agr;5&bgr;1 and &agr;6&bgr;4 integrin targeting enhances gene delivery and selectivity to cancer cells

  2017cites this paper
• Iron Chelation Nanoparticles with Delayed Saturation as an Effective Therapy for Parkinson Disease.

  2017cites this paper
• Harnessing supramolecular peptide nanotechnology in biomedical applications

  2017cites this paper
• Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy

  2017cites this paper
• Enhanced EGFR Targeting Activity of Plasmonic Nanostructures with Engineered GE11 Peptide

  2017cites this paper
• Peptide-targeted polymer cancerostatics.

  2016cites this paper
• N,O-Bis(trimethylsilyl)acetamide/N-hydroxysuccinimide ester (BSA/NHS) as coupling agents for dipeptide synthesis

  2016cites this paper
• Optimization of the tumor microenvironment and nanomedicine properties simultaneously to improve tumor therapy

  2016cites this paper
• Efficient and synergetic DNA delivery with pyridinium amphiphiles-gold nanoparticle composite systems having different packing parameters.

  2016cites this paper
• Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo.

  2016cites this paper
• A novel o-nitrobenzyl-based photocleavable antitumor prodrug with the capability of releasing 5-fluorourail

  2016cites this paper